FOSL1 and colitis: Future studies should validate hub genes in prospective clinical trials controlling for confounders and utilize animal models, such as myeloid-specific Fra-1 knockout in DSS-induced colitis, to assess its impact on M2 polarization, efferocytosis, and disease severity.